D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
CALL
Tucows
TCX
$97.1M
| $398K | ﹤0.01% |
+4,900
| New | +$357K |
|
3052
Winmark
WINA
$1.19B
| $397K | ﹤0.01% |
2,103
+24
| +1% | +$3.95K |
|
3053
Green Plains
GPRE
$1.19B
| $395K | ﹤0.01% |
+23,700
| New | +$355K |
|
3054
Novanta
NOVT
$5.04B
| $395K | ﹤0.01% |
4,659
-45,978
| -91% | -$3.45M |
|
3055
PUT
AngloGold Ashanti
AU
$40.3B
| $393K | ﹤0.01% |
30,000
-30,400
| -50% | -$409K |
|
3056
PUT
Brunswick
BC
$5.19B
| $393K | ﹤0.01% |
7,800
| – | – |
|
|
AL
3057
CALL
DELISTED
Air Lease Corp
AL
| $392K | ﹤0.01% |
+11,400
| New | +$411K |
|
3058
CALL
Cigna
CI
$76.6B
| $390K | ﹤0.01% |
2,424
| – | – |
|
3059
Dorian LPG
LPG
$1.94B
| $389K | ﹤0.01% |
60,574
-13,261
| -18% | -$77.7K |
|
3060
Atlanta Braves Holdings Series A
BATRA
$3.53B
| $388K | ﹤0.01% |
13,881
+451
| +3% | +$12.4K |
|
3061
First Merchants
FRME
$2.72B
| $388K | ﹤0.01% |
10,518
-28,014
| -73% | -$1.07M |
|
|
VIA
3062
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $386K | ﹤0.01% |
8,676
+4,769
| +122% | +$209K |
|
|
SIEN
3063
CALL
DELISTED
Sientra, Inc.
SIEN
| $386K | ﹤0.01% |
4,500
| – | – |
|
3064
Ameren
AEE
$31.5B
| $385K | ﹤0.01% |
5,231
-3,861
| -42% | -$269K |
|
3065
Exelon
EXC
$48.6B
| $384K | ﹤0.01% |
10,732
-5,188
| -33% | -$177K |
|
3066
PUT
FMC
FMC
$1.42B
| $384K | ﹤0.01% |
5,000
-765
| -13% | -$56.1K |
|
3067
Nordson
NDSN
$16.5B
| $384K | ﹤0.01% |
2,900
-9,435
| -76% | -$1.23M |
|
3068
CALL
Fluor
FLR
$7.29B
| $383K | ﹤0.01% |
+10,400
| New | +$380K |
|
3069
CALL
Omega Healthcare
OHI
$15.4B
| $382K | ﹤0.01% |
10,000
-45,100
| -82% | -$1.67M |
|
|
CRZO
3070
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $381K | ﹤0.01% |
+30,549
| New | +$363K |
|
3071
Q2 Holdings
QTWO
$3.42B
| $378K | ﹤0.01% |
5,459
-65,655
| -92% | -$4.1M |
|
|
CVA
3072
DELISTED
Covanta Holding Corporation
CVA
| $377K | ﹤0.01% |
21,792
-38,121
| -64% | -$623K |
|
|
BNY
3073
Bank of New York Mellon
BNY
$108B
| $376K | ﹤0.01% |
+7,460
| New | +$384K |
|
3074
Element Solutions
ESI
$9.12B
| $376K | ﹤0.01% |
37,259
-195,677
| -84% | -$2.17M |
|
3075
PUT
Essex Property Trust
ESS
$18.9B
| $376K | ﹤0.01% |
+1,300
| New | +$355K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.